Hydrogen Peroxide 50%
We will be really glad to make business with your company. So in case of your interest in our products you will be offered our competitive prices. For further information about our company and products please do not hesisate to contact to us.| Synonym: | Hydrogen Peroxide 50%, Perhydrol, Hyperox 50 |
| Trade Name: | PASHA 50 |
| Grade: | Technical Grade (standard industrial grade) |
| Chemical Formula: | H2O2 |
| CAS-No.: | 7722-84-1 |
| UN-No.: | 2014 |
| Hazard Symbols: | 
 |
| EU Classification: | O C |
| UN Classification: | UN Hazard Class: 5.1, UN additional dangers: 8, UN Packing Group: II |
| Boiling point: | 122°C |
| Melting Point: | -54,5°C |
Features: The colorless liquid can be heated or under the influence of light oxygen form. Consequently, the oxidizing and can spark or form explosive mixtures. Even in the heat or contact with metal catalysts, there is increased fire and explosion hazard. The substance is a strong oxidizing agents and reacts violently with reducing and / or combustible materials. He attacks organic materials (such as textiles and paper) to.
Symptoms: When inhaled a host is to cough, dizziness, headache, sore throat and nausea.There is the danger of toxic pulmonary edema. On the substance of the skin causes pain, a redness, burns and burns. A blurred sight is the first signs of an effect on the eyes. In addition, pain, redness, burns and burns to recognize. In a recording oral joined abdominal pain, nausea, vomiting and flatulence on.
Actions: The patients are under the consideration of self-protection from the contaminated environment to save. Each patient receives obligate oxygen. Affected areas of skin with plenty of water to rinse. When the exposure to the eye is this to anesthesia and rinse thoroughly. The substance can be absorbed orally, not with coal bound. To the corrosivity of the esophagus is to reduce this by drinking 300 ml of water are. The patients received inhaled and injectable corticosteroids. Because of the danger of toxic pulmonary edema, the patient for at least three days to monitor clinically.